← FDA DRUG APPROVALS

FDA ANDA · ANDA202350

MEMANTINE HYDROCHLORIDE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA202350
TYPE
ANDA
ORIGINAL APPROVAL
2017-05-23
LATEST ACTION
2020-04-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEMANTINE HYDROCHLORIDEDiscontinued
MEMANTINE HYDROCHLORIDE 5MG · TABLET · ORAL
MEMANTINE HYDROCHLORIDEDiscontinued
MEMANTINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2020-04-10Labeling · Supplement 1 · standardAP
2017-05-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →